" To make oral version of a diabetes medicine called Semaglutide"
If the price is right I'm sure MHR would consider a sale, but what is that magic number?
Maybe one of their investments will be the acquisition of Emisphere.
it was the last article titled Emisphere's Undervalued Diabetes Pill Partnership is an Oversized Opportunity by PLM Investments. Look at comments by 25294033
correction, Rodman & Renshaw